These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38724880)

  • 1. Sex and disease severity-based analysis of steroid hormones in ME/CFS.
    Pipper C; Bliem L; León LE; Mennickent D; Bodner C; Guzmán-Gutiérrez E; Stingl M; Untersmayr E; Wagner B; Bertinat R; Sepúlveda N; Westermeier F
    J Endocrinol Invest; 2024 May; ():. PubMed ID: 38724880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The underlying sex differences in neuroendocrine adaptations relevant to Myalgic Encephalomyelitis Chronic Fatigue Syndrome.
    Thomas N; Gurvich C; Huang K; Gooley PR; Armstrong CW
    Front Neuroendocrinol; 2022 Jul; 66():100995. PubMed ID: 35421511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms.
    Nkiliza A; Parks M; Cseresznye A; Oberlin S; Evans JE; Darcey T; Aenlle K; Niedospial D; Mullan M; Crawford F; Klimas N; Abdullah L
    J Transl Med; 2021 Aug; 19(1):370. PubMed ID: 34454515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductions in Cerebral Blood Flow Can Be Provoked by Sitting in Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients.
    Campen CLMV; Rowe PC; Visser FC
    Healthcare (Basel); 2020 Oct; 8(4):. PubMed ID: 33050553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Melvin A; Lacerda E; Dockrell HM; O'Rahilly S; Nacul L
    J Transl Med; 2019 Dec; 17(1):409. PubMed ID: 31801546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of circulating biomarkers with illness severity measures differentiates myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID-19 condition: a prospective pilot cohort study.
    Domingo JC; Battistini F; Cordobilla B; Zaragozá MC; Sanmartin-Sentañes R; Alegre-Martin J; Cambras T; Castro-Marrero J
    J Transl Med; 2024 Apr; 22(1):343. PubMed ID: 38600563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Typing myalgic encephalomyelitis by infection at onset: A DecodeME study.
    Bretherick AD; McGrath SJ; Devereux-Cooke A; Leary S; Northwood E; Redshaw A; Stacey P; Tripp C; Wilson J; Chowdhury S; Lewis I; Almelid Ø; Baby SV; Baker T; Becher H; Boutin T; Clyde M; Garcia D; Ireland J; Kerr SM; McDowall E; Perry D; Samms GL; Vitart V; Wolfe JC; Ponting CP
    NIHR Open Res; 2023; 3():20. PubMed ID: 37881452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls.
    Giloteaux L; Li J; Hornig M; Lipkin WI; Ruppert D; Hanson MR
    J Transl Med; 2023 May; 21(1):322. PubMed ID: 37179299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP
    Eaton-Fitch N; Cabanas H; du Preez S; Staines D; Marshall-Gradisnik S
    J Transl Med; 2021 Jul; 19(1):306. PubMed ID: 34266470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplexed steroid profiling of gluco- and mineralocorticoids pathways using a liquid chromatography tandem mass spectrometry method.
    Travers S; Martinerie L; Bouvattier C; Boileau P; Lombès M; Pussard E
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):202-211. PubMed ID: 27339652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The High Relevance of 21-Deoxycortisol, (Androstenedione + 17α-Hydroxyprogesterone)/Cortisol, and 11-Deoxycortisol/17α-Hydroxyprogesterone for Newborn Screening of 21-Hydroxylase Deficiency.
    Watanabe K; Tsuji-Hosokawa A; Hashimoto A; Konishi K; Ishige N; Yajima H; Sutani A; Nakatani H; Gau M; Takasawa K; Tajima T; Hasegawa T; Morio T; Kashimada K
    J Clin Endocrinol Metab; 2022 Nov; 107(12):3341-3352. PubMed ID: 36071550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of CD8 T-cell dysfunction associated with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and Long COVID and treatment with a nebulized antioxidant/anti-pathogen agent in a retrospective case series.
    Gil A; Hoag GE; Salerno JP; Hornig M; Klimas N; Selin LK
    Brain Behav Immun Health; 2024 Mar; 36():100720. PubMed ID: 38327880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connectivity Between Salience and Default Mode Networks and Subcortical Nodes Distinguishes Between Two Classes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Su J; Thapaliya K; Eaton-Fitch N; Marshall-Gradisnik S; Barnden L
    Brain Connect; 2023 Apr; 13(3):164-173. PubMed ID: 36352819
    [No Abstract]   [Full Text] [Related]  

  • 14. Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study.
    Mensah F; Bansal A; Berkovitz S; Sharma A; Reddy V; Leandro MJ; Cambridge G
    Clin Exp Immunol; 2016 May; 184(2):237-47. PubMed ID: 26646713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study.
    Giloteaux L; O'Neal A; Castro-Marrero J; Levine SM; Hanson MR
    J Transl Med; 2020 Oct; 18(1):387. PubMed ID: 33046133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal resting state functional connectivity in patients with chronic fatigue syndrome: an arterial spin-labeling fMRI study.
    Boissoneault J; Letzen J; Lai S; O'Shea A; Craggs J; Robinson ME; Staud R
    Magn Reson Imaging; 2016 May; 34(4):603-8. PubMed ID: 26708036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age- and sex-adjusted reference intervals for steroid hormones measured by liquid chromatography-tandem mass spectrometry using a widely available kit.
    Kunz S; Wang X; Ferrari U; Drey M; Theodoropoulou M; Schilbach K; Reincke M; Heier M; Peters A; Koenig W; Zeller T; Thorand B; Bidlingmaier M
    Endocr Connect; 2024 Jan; 13(1):. PubMed ID: 37938144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of Cortical Volume and Thickness in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Thapaliya K; Marshall-Gradisnik S; Staines D; Su J; Barnden L
    Front Neurosci; 2022; 16():848730. PubMed ID: 35527811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of serum cortisol and cortisone levels and risk of recurrence after endocrine treatment in breast cancer.
    Wang F; Giskeødegård GF; Skarra S; Engstrøm MJ; Hagen L; Geisler J; Mikkola TS; Tikkanen MJ; Debik J; Reidunsdatter RJ; Bathen TF
    Clin Exp Med; 2023 Nov; 23(7):3883-3893. PubMed ID: 37395895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Shukla SK; Cook D; Meyer J; Vernon SD; Le T; Clevidence D; Robertson CE; Schrodi SJ; Yale S; Frank DN
    PLoS One; 2015; 10(12):e0145453. PubMed ID: 26683192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.